Universal vaccine advancement through AI and recombinant technology

In this interview, News-Medical talks to Dr. Amy Sheng and Dr. Lurong Pan about how AI computing can be used in combination with high throughput production and screening to enhance the development process for potential universal vaccines.

Related Keywords

United States ,Georgia ,Nanjing ,Jiangsu ,China ,Georgia Institute Of Technology ,Alex Smith ,Lurong Pan ,Ainnocence ,Amy Sheng ,Ceosino Biological Inc ,Global Health Drug Discovery Institute ,Inc Twitter ,University Of Alabama ,Linkedin ,Twitter ,Sino Biological Inc ,University Of Alabama At Birmingham ,Sino Biological Inc Oct ,Sponsored Content ,Lurong Pantechnical Account Manager ,Biological Inc ,Sino Biological ,Caprico Biotechnologies ,Cell Biology ,Georgia Institute ,Applied Chemistry ,Nanjing University ,Computer Science ,Georgia Tech ,Vaccine ,Animal Model ,Antibodies ,Ntibody ,Ntigen ,Artificial Intelligence ,B Cell ,Biotechnology ,Fell ,Na ,Drug Discovery ,Efficacy ,Revolution ,High Throughput ,Immune Response ,Immune System ,Immunity ,Influenza ,Molecular Biology ,Monoclonal Antibody ,Mh ,Protein ,Research ,Cars ,Herapeutics ,Virus ,